LBT INNOVATIONS LIMITED - Announcements

Market Cap $21.47M Add to my watchlist

Healthcare Medical Devices

LBT Innovations is a ground-breaking designer of advanced technology solutions for the... LBT Innovations is a ground-breaking designer of advanced technology solutions for the medical industry. We specialise in combining artificial intelligence, image analysis and software engineering to improve healthcare delivery. Our product, APAS® Independence, is a global first solution for automated reading of microbiology culture plates.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

LBT	Appendix 4C - quarterly	PRICE SENSITIVE	26/04/17	209.65KB	Share
LBT	LBT Business Update		30/03/17	3.46MB	Share
LBT	APAS Independence Demonstration Device Ready Ahead of ECCMID		30/03/17	219.09KB	Share
LBT	APAS INCLUDED ON THE AUSTRALIAN TGA REGISTER	PRICE SENSITIVE	28/03/17	216.88KB	Share
LBT	Appendix 3B		03/03/17	193KB	Share
LBT	Half Yearly Report and Accounts	PRICE SENSITIVE	27/02/17	4.68MB	Share
LBT	LBT Business Update		08/02/17	1.42MB	Share
LBT	LBT to Present at Melbourne Investor Forum		08/02/17	180.87KB	Share
LBT	Appendix 3B		31/01/17	193.31KB	Share
LBT	Appendix 4C - quarterly	PRICE SENSITIVE	31/01/17	93.69KB	Share
LBT	Notice Under Section 708A		30/01/17	112.25KB	Share
LBT	Change of Director's Interest Notice		30/01/17	265.27KB	Share
LBT	Change of Director's Interest Notice		30/01/17	256.71KB	Share
LBT	Change of Director's Interest Notice		30/01/17	256.08KB	Share
LBT	Change of Director's Interest Notice		30/01/17	257.67KB	Share
LBT	Appendix 3B		25/01/17	195.06KB	Share
LBT	Results of Meeting		18/01/17	108.82KB	Share
LBT	EGM CEO Presentation		18/01/17	820.87KB	Share
LBT	Becoming a substantial holder		21/12/16	1.61MB	Share
LBT	Notice of Extraordinary General Meeting/Proxy Form		14/12/16	358.09KB	Share
LBT	Ceasing to be a substantial holder		14/12/16	732.49KB	Share
LBT	Placement Cleansing Notice		12/12/16	36.45KB	Share
LBT	Appendix 3B		12/12/16	193.7KB	Share
LBT	Investor Presentation - Placement		02/12/16	3.17MB	Share
LBT	Completion of Placement	PRICE SENSITIVE	02/12/16	46.33KB	Share
LBT	Trading Halt	PRICE SENSITIVE	30/11/16	280.81KB	Share
LBT	Change of Director's Interest Notice - B Barnes		18/11/16	111.46KB	Share
LBT	Appendix 3B		18/11/16	194.33KB	Share
LBT	Change of Auditor Details		18/11/16	35.81KB	Share
LBT	Results of Meeting		16/11/16	104.11KB	Share
LBT	CEO Presentation - AGM 2016		16/11/16	1.5MB	Share
LBT	Chairman's Address to Shareholders		16/11/16	127.58KB	Share
LBT	LBT Innovations Granted New Patent for United States	PRICE SENSITIVE	11/11/16	229.58KB	Share
LBT	Change of Director's Interest Notice-LBT.AX		27/10/16	415.04KB	Share
LBT	Company update-LBT.AX		27/10/16	1.72MB	Share
LBT	Appendix 4C - quarterly-LBT.AX	PRICE SENSITIVE	27/10/16	93.98KB	Share
LBT	Notice of initial substantial holder-LBT.AX		26/10/16	1.38MB	Share
LBT	Change of Director's Interest Notice-LBT.AX		21/10/16	112.62KB	Share
LBT	Change of Director's Interest Notice-LBT.AX		21/10/16	113.07KB	Share
LBT	Change of Director's Interest Notice-LBT.AX		21/10/16	111.56KB	Share
LBT	Change of Director's Interest Notice-LBT.AX		21/10/16	119.98KB	Share
LBT	Ceasing to be a substantial holder-LBT.AX		21/10/16	131.75KB	Share
LBT	Appendix 3B-LBT.AX		20/10/16	194.01KB	Share
LBT	Ceasing to be a substantial holder-LBT.AX		18/10/16	495.63KB	Share
LBT	Appendix 3B-LBT.AX		14/10/16	677.77KB	Share
LBT	Notice of Annual General Meeting/Proxy Form-LBT.AX		14/10/16	951.56KB	Share
LBT	Appendix 3B-LBT.AX		13/10/16	193.37KB	Share
LBT	Change of Director's Interest Notice-LBT.AX		12/10/16	159.46KB	Share
LBT	Appendix 3B-LBT.AX		11/10/16	193.18KB	Share
LBT	US FDA GRANTS APPROVAL FOR APAS-LBT.AX	PRICE SENSITIVE	10/10/16	110.43KB	Share
LBT	Appendix 4G-LBT.AX		28/09/16	372.32KB	Share
LBT	Annual Report to shareholders-LBT.AX		28/09/16	3.43MB	Share
LBT	LBT to Present at AusBiotech Broker Meets Biotech Event-LBT.AX		22/09/16	1.05MB	Share
LBT	Preliminary Final Report-LBT.AX	PRICE SENSITIVE	31/08/16	604.89KB	Share
LBT	Initial Director's Interest Notice-LBT.AX		09/08/16	99.64KB	Share
LBT	Final Director's Interest Notice-LBT.AX		09/08/16	97.73KB	Share
LBT	Appendix 4C - quarterly-LBT.AX	PRICE SENSITIVE	29/07/16	132.11KB	Share
LBT	Retiring LBT CEO Lusia Guthrie Appointed Chair of CCS AG-LBT.AX		10/06/16	118.14KB	Share
LBT	LBT granted patent in Japan for core APAS technology-LBT.AX	PRICE SENSITIVE	19/05/16	95.51KB	Share
LBT	Cochlear Executive Brent Barnes Appointed CEO of LBT-LBT.AX	PRICE SENSITIVE	09/05/16	118.17KB	Share
LBT	Appendix 3B-LBT.AX		09/05/16	558.22KB	Share
LBT	Appendix 4C - quarterly-LBT.AX	PRICE SENSITIVE	26/04/16	324.36KB	Share
LBT	LBT Receives Notice of Allowance for Third Patent-LBT.AX	PRICE SENSITIVE	07/04/16	114.53KB	Share
LBT	Change of Director's Interest Notice		11/03/16	234.66KB	Share
LBT	Half Yearly Report and Accounts	PRICE SENSITIVE	29/02/16	511.39KB	Share
LBT	Appendix 4C - quarterly	PRICE SENSITIVE	29/01/16	430.6KB	Share
LBT	LBT Innovations Completes U.S. Regulatory Submission	PRICE SENSITIVE	22/12/15	108.57KB	Share
LBT	LBT Concludes APAS Clinical Trial Program	PRICE SENSITIVE	16/11/15	106.1KB	Share
LBT	Appendix 3B		09/11/15	561.08KB	Share
LBT	Results of Meeting		21/10/15	108.39KB	Share
LBT	AGM 2015 CEO Presentation		21/10/15	1.11MB	Share
LBT	Chairman's Address to Shareholders		21/10/15	141.7KB	Share
LBT	Appendix 4C - quarterly	PRICE SENSITIVE	20/10/15	345.88KB	Share
LBT	LBT Receives Notice of Allowance for Second Patent	PRICE SENSITIVE	14/10/15	105.14KB	Share
LBT	LBT CEO Retirement	PRICE SENSITIVE	12/10/15	160.19KB	Share
LBT	APAS Exceeds Expectations in Key U.S. Clinical Trials	PRICE SENSITIVE	07/10/15	241.63KB	Share
LBT	Appendix 4G		25/09/15	744.2KB	Share
LBT	Annual Report to shareholders		25/09/15	2.95MB	Share
LBT	Notice of Annual General Meeting/Proxy Form		18/09/15	383.54KB	Share
LBT	Resubmission of 3Y - 17 September 2015		18/09/15	426.71KB	Share
LBT	Change of Director's Interest Notice		18/09/15	236.25KB	Share
LBT	Change of Director's Interest Notice		17/09/15	356.78KB	Share
LBT	Change of Director's Interest Notice		04/09/15	236.18KB	Share
LBT	Change of Director's Interest Notice		01/09/15	232.64KB	Share
LBT	LBT Innovations Market Update	PRICE SENSITIVE	28/08/15	188.76KB	Share
LBT	Preliminary Final Report	PRICE SENSITIVE	27/08/15	570.98KB	Share
LBT	LBT Signs Agreement with bioMerieux	PRICE SENSITIVE	27/08/15	189.48KB	Share
LBT	Change in substantial holding		31/07/15	76.42KB	Share
LBT	Appendix 4C - quarterly	PRICE SENSITIVE	31/07/15	167.67KB	Share
LBT	Change in substantial holding		30/07/15	965.51KB	Share
LBT	LBT begins key U.S. trial of APAS technology	PRICE SENSITIVE	09/06/15	182.95KB	Share
LBT	Appendix 4C - quarterly	PRICE SENSITIVE	28/04/15	132.39KB	Share
LBT	Shareholder News - April 2015		30/03/15	6.21MB	Share
LBT	LBT Granted First U.S. Patent for APAS Technology	PRICE SENSITIVE	26/03/15	84.82KB	Share
LBT	Appendix 4D	PRICE SENSITIVE	27/02/15	4.11MB	Share
LBT	Appendix 4C - quarterly	PRICE SENSITIVE	30/01/15	282.9KB	Share
LBT	Notice of Intent re PREVI Isola Licence Agreement	PRICE SENSITIVE	12/01/15	166.98KB	Share
LBT	CEO Presentation at Ausbiotech Biotech Invest Summit		03/12/14	1.11MB	Share
LBT	LBT Completes Australian Clinical Trials of APAS Technology	PRICE SENSITIVE	26/11/14	105.42KB	Share
LBT	Change of Company Secretary		20/11/14	89.52KB	Share

LBT Appendix 4C - quarterly
26/04/17	PRICE SENSITIVE	209.65KB	Share
LBT LBT Business Update
30/03/17		3.46MB	Share
LBT APAS Independence Demonstration Device Ready Ahead of ECCMID
30/03/17		219.09KB	Share
LBT APAS INCLUDED ON THE AUSTRALIAN TGA REGISTER
28/03/17	PRICE SENSITIVE	216.88KB	Share
LBT Appendix 3B
03/03/17		193KB	Share
LBT Half Yearly Report and Accounts
27/02/17	PRICE SENSITIVE	4.68MB	Share
LBT LBT Business Update
08/02/17		1.42MB	Share
LBT LBT to Present at Melbourne Investor Forum
08/02/17		180.87KB	Share
LBT Appendix 3B
31/01/17		193.31KB	Share
LBT Appendix 4C - quarterly
31/01/17	PRICE SENSITIVE	93.69KB	Share
LBT Notice Under Section 708A
30/01/17		112.25KB	Share
LBT Change of Director's Interest Notice
30/01/17		265.27KB	Share
LBT Change of Director's Interest Notice
30/01/17		256.71KB	Share
LBT Change of Director's Interest Notice
30/01/17		256.08KB	Share
LBT Change of Director's Interest Notice
30/01/17		257.67KB	Share
LBT Appendix 3B
25/01/17		195.06KB	Share
LBT Results of Meeting
18/01/17		108.82KB	Share
LBT EGM CEO Presentation
18/01/17		820.87KB	Share
LBT Becoming a substantial holder
21/12/16		1.61MB	Share
LBT Notice of Extraordinary General Meeting/Proxy Form
14/12/16		358.09KB	Share
LBT Ceasing to be a substantial holder
14/12/16		732.49KB	Share
LBT Placement Cleansing Notice
12/12/16		36.45KB	Share
LBT Appendix 3B
12/12/16		193.7KB	Share
LBT Investor Presentation - Placement
02/12/16		3.17MB	Share
LBT Completion of Placement
02/12/16	PRICE SENSITIVE	46.33KB	Share
LBT Trading Halt
30/11/16	PRICE SENSITIVE	280.81KB	Share
LBT Change of Director's Interest Notice - B Barnes
18/11/16		111.46KB	Share
LBT Appendix 3B
18/11/16		194.33KB	Share
LBT Change of Auditor Details
18/11/16		35.81KB	Share
LBT Results of Meeting
16/11/16		104.11KB	Share
LBT CEO Presentation - AGM 2016
16/11/16		1.5MB	Share
LBT Chairman's Address to Shareholders
16/11/16		127.58KB	Share
LBT LBT Innovations Granted New Patent for United States
11/11/16	PRICE SENSITIVE	229.58KB	Share
LBT Change of Director's Interest Notice-LBT.AX
27/10/16		415.04KB	Share
LBT Company update-LBT.AX
27/10/16		1.72MB	Share
LBT Appendix 4C - quarterly-LBT.AX
27/10/16	PRICE SENSITIVE	93.98KB	Share
LBT Notice of initial substantial holder-LBT.AX
26/10/16		1.38MB	Share
LBT Change of Director's Interest Notice-LBT.AX
21/10/16		112.62KB	Share
LBT Change of Director's Interest Notice-LBT.AX
21/10/16		113.07KB	Share
LBT Change of Director's Interest Notice-LBT.AX
21/10/16		111.56KB	Share
LBT Change of Director's Interest Notice-LBT.AX
21/10/16		119.98KB	Share
LBT Ceasing to be a substantial holder-LBT.AX
21/10/16		131.75KB	Share
LBT Appendix 3B-LBT.AX
20/10/16		194.01KB	Share
LBT Ceasing to be a substantial holder-LBT.AX
18/10/16		495.63KB	Share
LBT Appendix 3B-LBT.AX
14/10/16		677.77KB	Share
LBT Notice of Annual General Meeting/Proxy Form-LBT.AX
14/10/16		951.56KB	Share
LBT Appendix 3B-LBT.AX
13/10/16		193.37KB	Share
LBT Change of Director's Interest Notice-LBT.AX
12/10/16		159.46KB	Share
LBT Appendix 3B-LBT.AX
11/10/16		193.18KB	Share
LBT US FDA GRANTS APPROVAL FOR APAS-LBT.AX
10/10/16	PRICE SENSITIVE	110.43KB	Share
LBT Appendix 4G-LBT.AX
28/09/16		372.32KB	Share
LBT Annual Report to shareholders-LBT.AX
28/09/16		3.43MB	Share
LBT LBT to Present at AusBiotech Broker Meets Biotech Event-LBT.AX
22/09/16		1.05MB	Share
LBT Preliminary Final Report-LBT.AX
31/08/16	PRICE SENSITIVE	604.89KB	Share
LBT Initial Director's Interest Notice-LBT.AX
09/08/16		99.64KB	Share
LBT Final Director's Interest Notice-LBT.AX
09/08/16		97.73KB	Share
LBT Appendix 4C - quarterly-LBT.AX
29/07/16	PRICE SENSITIVE	132.11KB	Share
LBT Retiring LBT CEO Lusia Guthrie Appointed Chair of CCS AG-LBT.AX
10/06/16		118.14KB	Share
LBT LBT granted patent in Japan for core APAS technology-LBT.AX
19/05/16	PRICE SENSITIVE	95.51KB	Share
LBT Cochlear Executive Brent Barnes Appointed CEO of LBT-LBT.AX
09/05/16	PRICE SENSITIVE	118.17KB	Share
LBT Appendix 3B-LBT.AX
09/05/16		558.22KB	Share
LBT Appendix 4C - quarterly-LBT.AX
26/04/16	PRICE SENSITIVE	324.36KB	Share
LBT LBT Receives Notice of Allowance for Third Patent-LBT.AX
07/04/16	PRICE SENSITIVE	114.53KB	Share
LBT Change of Director's Interest Notice
11/03/16		234.66KB	Share
LBT Half Yearly Report and Accounts
29/02/16	PRICE SENSITIVE	511.39KB	Share
LBT Appendix 4C - quarterly
29/01/16	PRICE SENSITIVE	430.6KB	Share
LBT LBT Innovations Completes U.S. Regulatory Submission
22/12/15	PRICE SENSITIVE	108.57KB	Share
LBT LBT Concludes APAS Clinical Trial Program
16/11/15	PRICE SENSITIVE	106.1KB	Share
LBT Appendix 3B
09/11/15		561.08KB	Share
LBT Results of Meeting
21/10/15		108.39KB	Share
LBT AGM 2015 CEO Presentation
21/10/15		1.11MB	Share
LBT Chairman's Address to Shareholders
21/10/15		141.7KB	Share
LBT Appendix 4C - quarterly
20/10/15	PRICE SENSITIVE	345.88KB	Share
LBT LBT Receives Notice of Allowance for Second Patent
14/10/15	PRICE SENSITIVE	105.14KB	Share
LBT LBT CEO Retirement
12/10/15	PRICE SENSITIVE	160.19KB	Share
LBT APAS Exceeds Expectations in Key U.S. Clinical Trials
07/10/15	PRICE SENSITIVE	241.63KB	Share
LBT Appendix 4G
25/09/15		744.2KB	Share
LBT Annual Report to shareholders
25/09/15		2.95MB	Share
LBT Notice of Annual General Meeting/Proxy Form
18/09/15		383.54KB	Share
LBT Resubmission of 3Y - 17 September 2015
18/09/15		426.71KB	Share
LBT Change of Director's Interest Notice
18/09/15		236.25KB	Share
LBT Change of Director's Interest Notice
17/09/15		356.78KB	Share
LBT Change of Director's Interest Notice
04/09/15		236.18KB	Share
LBT Change of Director's Interest Notice
01/09/15		232.64KB	Share
LBT LBT Innovations Market Update
28/08/15	PRICE SENSITIVE	188.76KB	Share
LBT Preliminary Final Report
27/08/15	PRICE SENSITIVE	570.98KB	Share
LBT LBT Signs Agreement with bioMerieux
27/08/15	PRICE SENSITIVE	189.48KB	Share
LBT Change in substantial holding
31/07/15		76.42KB	Share
LBT Appendix 4C - quarterly
31/07/15	PRICE SENSITIVE	167.67KB	Share
LBT Change in substantial holding
30/07/15		965.51KB	Share
LBT LBT begins key U.S. trial of APAS technology
09/06/15	PRICE SENSITIVE	182.95KB	Share
LBT Appendix 4C - quarterly
28/04/15	PRICE SENSITIVE	132.39KB	Share
LBT Shareholder News - April 2015
30/03/15		6.21MB	Share
LBT LBT Granted First U.S. Patent for APAS Technology
26/03/15	PRICE SENSITIVE	84.82KB	Share
LBT Appendix 4D
27/02/15	PRICE SENSITIVE	4.11MB	Share
LBT Appendix 4C - quarterly
30/01/15	PRICE SENSITIVE	282.9KB	Share
LBT Notice of Intent re PREVI Isola Licence Agreement
12/01/15	PRICE SENSITIVE	166.98KB	Share
LBT CEO Presentation at Ausbiotech Biotech Invest Summit
03/12/14		1.11MB	Share
LBT LBT Completes Australian Clinical Trials of APAS Technology
26/11/14	PRICE SENSITIVE	105.42KB	Share
LBT Change of Company Secretary
20/11/14		89.52KB	Share

REFRESH

First 4 5 6 7 8

(20min delay)
Last 1.3¢		Change -0.001(7.14%)		Mkt cap ! $21.47M

Open	High	Low	Value	Volume
1.4¢	1.4¢	1.3¢	$12.8K	950K

Buyers (Bids)

No.	Vol.	Price($)
6	4268596	1.3¢

Sellers (Offers)

Price($)	Vol.	No.
1.4¢	197886	2

View Market Depth

No.	Vol.	Price($)
5	4245520	0.013
3	7333332	0.012
6	806500	0.011
5	1089004	0.010
3	256759	0.009

Price($)	Vol.	No.
0.015	429699	3
0.016	931586	6
0.017	990881	7
0.018	457000	3
0.020	115000	1

Last trade - 14.43pm 20/09/2024 (20 minute delay)


Last 1.3¢		Change -0.001 ( 3.70 %)
Open	High	Low	Volume
1.5¢	1.5¢	1.3¢	662691
Last updated 15.59pm 20/09/2024 ?

LBT (ASX) Chart

LBT INNOVATIONS LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available